115 related articles for article (PubMed ID: 23826075)
1. Mutations in Mll2, an H3K4 methyltransferase, result in insulin resistance and impaired glucose tolerance in mice.
Goldsworthy M; Absalom NL; Schröter D; Matthews HC; Bogani D; Moir L; Long A; Church C; Hugill A; Anstee QM; Goldin R; Thursz M; Hollfelder F; Cox RD
PLoS One; 2013; 8(6):e61870. PubMed ID: 23826075
[TBL] [Abstract][Full Text] [Related]
2. Mutation of cancer driver MLL2 results in transcription stress and genome instability.
Kantidakis T; Saponaro M; Mitter R; Horswell S; Kranz A; Boeing S; Aygün O; Kelly GP; Matthews N; Stewart A; Stewart AF; Svejstrup JQ
Genes Dev; 2016 Feb; 30(4):408-20. PubMed ID: 26883360
[TBL] [Abstract][Full Text] [Related]
3. Structure, Activity and Function of the MLL2 (KMT2B) Protein Lysine Methyltransferase.
Klonou A; Chlamydas S; Piperi C
Life (Basel); 2021 Aug; 11(8):. PubMed ID: 34440566
[TBL] [Abstract][Full Text] [Related]
4. The cancer COMPASS: navigating the functions of MLL complexes in cancer.
Ford DJ; Dingwall AK
Cancer Genet; 2015 May; 208(5):178-91. PubMed ID: 25794446
[TBL] [Abstract][Full Text] [Related]
5. Mll2 is required for H3K4 trimethylation on bivalent promoters in embryonic stem cells, whereas Mll1 is redundant.
Denissov S; Hofemeister H; Marks H; Kranz A; Ciotta G; Singh S; Anastassiadis K; Stunnenberg HG; Stewart AF
Development; 2014 Feb; 141(3):526-37. PubMed ID: 24423662
[TBL] [Abstract][Full Text] [Related]
6. On the evolutionary origins of obesity: a new hypothesis.
Sellayah D; Cagampang FR; Cox RD
Endocrinology; 2014 May; 155(5):1573-88. PubMed ID: 24605831
[TBL] [Abstract][Full Text] [Related]
7. An N-ethyl-N-nitrosourea induced corticotropin-releasing hormone promoter mutation provides a mouse model for endogenous glucocorticoid excess.
Bentley L; Esapa CT; Nesbit MA; Head RA; Evans H; Lath D; Scudamore CL; Hough TA; Podrini C; Hannan FM; Fraser WD; Croucher PI; Brown MA; Brown SD; Cox RD; Thakker RV
Endocrinology; 2014 Mar; 155(3):908-22. PubMed ID: 24302625
[TBL] [Abstract][Full Text] [Related]
8. Unraveling the relationship between histone methylation and nonalcoholic fatty liver disease.
Xu L; Fan YH; Zhang XJ; Bai L
World J Hepatol; 2024 May; 16(5):703-715. PubMed ID: 38818286
[TBL] [Abstract][Full Text] [Related]
9. KMT2 Family of H3K4 Methyltransferases: Enzymatic Activity-dependent and -independent Functions.
Van HT; Xie G; Dong P; Liu Z; Ge K
J Mol Biol; 2024 Apr; 436(7):168453. PubMed ID: 38266981
[TBL] [Abstract][Full Text] [Related]
10. Transcriptional co-activators: emerging roles in signaling pathways and potential therapeutic targets for diseases.
Talukdar PD; Chatterji U
Signal Transduct Target Ther; 2023 Nov; 8(1):427. PubMed ID: 37953273
[TBL] [Abstract][Full Text] [Related]
11. Histone Modifications in NAFLD: Mechanisms and Potential Therapy.
Shi Y; Qi W
Int J Mol Sci; 2023 Sep; 24(19):. PubMed ID: 37834101
[TBL] [Abstract][Full Text] [Related]
12. Diabetes mellitus and insulin resistance associated with Kabuki syndrome-A case report and literature review.
Thewjitcharoen Y; Wanothayaroj E; Nakasatien S; Krittiyawong S; Khurana I; El-Osta A; Himathongkam T
Clin Case Rep; 2022 Apr; 10(4):e05736. PubMed ID: 35441024
[TBL] [Abstract][Full Text] [Related]
13. Metabolic and Epigenetic Regulation by Estrogen in Adipocytes.
Bjune JI; Strømland PP; Jersin RÅ; Mellgren G; Dankel SN
Front Endocrinol (Lausanne); 2022; 13():828780. PubMed ID: 35273571
[TBL] [Abstract][Full Text] [Related]
14. Epigenetics and Beyond: Targeting Histone Methylation to Treat Type 2 Diabetes Mellitus.
Yang Y; Luan Y; Feng Q; Chen X; Qin B; Ren KD; Luan Y
Front Pharmacol; 2021; 12():807413. PubMed ID: 35087408
[TBL] [Abstract][Full Text] [Related]
15. Epigenetic modifications in pancreas development, diabetes, and therapeutics.
Kaimala S; Kumar CA; Allouh MZ; Ansari SA; Emerald BS
Med Res Rev; 2022 May; 42(3):1343-1371. PubMed ID: 34984701
[TBL] [Abstract][Full Text] [Related]
16. Histone Methylation Related Therapeutic Challenge in Cardiovascular Diseases.
Yang Y; Luan Y; Yuan RX; Luan Y
Front Cardiovasc Med; 2021; 8():710053. PubMed ID: 34568453
[TBL] [Abstract][Full Text] [Related]
17. Epigenetics of Hepatic Insulin Resistance.
Maude H; Sanchez-Cabanillas C; Cebola I
Front Endocrinol (Lausanne); 2021; 12():681356. PubMed ID: 34046015
[TBL] [Abstract][Full Text] [Related]
18. Epigenetic Regulation of Adipogenesis in Development of Metabolic Syndrome.
Pant R; Firmal P; Shah VK; Alam A; Chattopadhyay S
Front Cell Dev Biol; 2020; 8():619888. PubMed ID: 33511131
[TBL] [Abstract][Full Text] [Related]
19. Update on KMT2B-Related Dystonia.
Zech M; Lam DD; Winkelmann J
Curr Neurol Neurosci Rep; 2019 Nov; 19(11):92. PubMed ID: 31768667
[TBL] [Abstract][Full Text] [Related]
20. The Lysine Demethylase KDM5B Regulates Islet Function and Glucose Homeostasis.
Backe MB; Jin C; Andreone L; Sankar A; Agger K; Helin K; Madsen AN; Poulsen SS; Bysani M; Bacos K; Ling C; Perone MJ; Holst B; Mandrup-Poulsen T
J Diabetes Res; 2019; 2019():5451038. PubMed ID: 31467927
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
